英国肾去神经术治疗高血压的德尔菲专家共识
本研究采用改良德尔菲法,由七名多学科临床医生组成指导组,制定40条关于肾去神经术(RDN)的共识声明,并以在线调查形式征询英国参与高血压管理的临床医生意见,共识定义为75%同意。共收到125份回复,37/40条声明达成共识(93%),最终形成11条关键推荐,涵盖患者选择、多学科协作、培训与委托开展等方面。共识指出RDN应考虑用于难治性高血压或药物不耐受患者,并采用多学科方法。
要点
- RDN应考虑用于难治性高血压或对药物不耐受的患者。
- 共识采用多学科方法,涵盖患者选择、协作、培训与委托。
- 37/40条声明达成共识(93%),形成11条关键推荐。
核心结论
- 该专家共识定义了RDN的患者选择标准,并提供11条推荐以支持其使用。
- RDN应考虑用于难治性高血压或药物不耐受患者,并采用多学科方法。
研究设计与样本
- 采用改良德尔菲法,指导组由七名心脏病学、临床药理学、放射学、肾脏病学和全科医学临床医生组成,于2024年6月召开会议。
- 指导组制定40条共识声明,通过在线调查发给英国参与高血压管理的临床医生,采用四点Likert量表评估同意程度,共识预定义为75%同意。
主要发现
- 共收到125份回复,来自英国各地区的介入心脏病学家和放射学家、心脏病学家、临床药理学家和肾脏病学家。
- 40条声明中37条达成共识(93%)。
- 基于共识评分,指导组制定了11条关键推荐,涉及患者选择、多学科协作、临床医生培训和RDN委托开展。
关键数值与推荐
- 共识预定义为75%同意。
- 40条声明中37条达成共识(93%)。
- 形成11条关键推荐。
临床怎么用
- RDN应考虑用于难治性高血压或药物不耐受患者,采用多学科方法。
- 实施这些推荐可指导临床实践、为委托提供信息并支持英国国家卫生与临床优化研究所(NICE)的评审,最终改善英国患者可及性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Renal denervation (RDN) has emerged as a guideline-recommended therapeutic option in hypertension management with several high-quality, randomised, placebo-controlled trials demonstrating efficacy and safety. However, the lack of expert consensus on patient selection for RDN in the UK has led to debate regarding its use. This study aimed to establish a multidisciplinary consensus to provide clinicians and commissioners with guidance on the appropriate use of RDN in hypertension management within the UK. METHODS: The project used a modified Delphi method. A steering group (SG) of seven clinicians in cardiology, clinical pharmacology, radiology, nephrology and general practice, all experienced in managing patients with hypertension, convened in June 2024. The SG aligned on 40 consensus statements covering key topics (patient identification and selection, multidisciplinary team collaboration, commissioning and guidelines, training and education and awareness of RDN). The statements were distributed as an online survey to UK clinicians involved in hypertension management. Respondents assessed their level of agreement using a four-point Likert scale. Consensus was predefined as 75% agreement. The surveys were collated anonymously and independently analysed. The results were shared with the SG in November and December 2024. RESULTS: A total of 125 responses were received from interventional cardiologists and radiologists, cardiologists, clinical pharmacologists and nephrologists across various regions of the UK.Consensus was achieved for 37 out of 40 statements (93%). Based on the consensus scores, 11 key recommendations were developed by the SG regarding patient selection, multidisciplinary collaboration, clinician training and commissioning for RDN. CONCLUSIONS: This expert consensus defines patient selection criteria for RDN and provides 11 recommendations to support its use. RDN should be considered for resistant hypertension or intolerance to medications, using a multidisciplinary approach. Implementation of these recommendations could guide clinical practice, inform commissioning and support National Institute for Health and Care Excellence reviews, ultimately improving patient access across the UK.
引用
- Haworth, Bent, Chapman, et al. Renal denervation for hypertension management in the UK: a Delphi expert consensus. Heart. 2026. PMID: 41249033. doi:10.1136/heartjnl-2025-327110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。